Analysis of DC migration by i.v. application of indium labelled E/L-S DCclinical study dataset
We found that Indium111 labelled DC should not be loaded with tumor antigens if applied in patients, which may result in loss of specific immune responses and are testing this in-vivo.
Analysis of DC migration in vivo in a first patient by i.v. application of indium labelled E/L-S DC (without antigen loading) is scheduled for March 2009. Data will become available.